Newsarchiv

16. Juli 2009

Neue AppNote: Benzodiazepine in Urin mittels DPX-LC/MS/MS

Durch die Verwendung von Disposable Pipette Extraction DPX und LC/MS/MS kann auf eine Derivatisierung für den Nachweis von Benzodiazepinen in Urin verzichtet werden.

 

Abstract:

Analysis of benzodiazepines using GC/MS necessitates the use of derivatization, which has been shown to be a limitation for some of the benzodiazepines. The analysis of automated DPX extracted benzodiazepines using LC/MS/MS was chosen in an attempt to eliminate the need for derivatization.
Previous data described in Agilent Application Notes show the use of an Agilent 6410 LC/MS/MS instrument to be a highly sensitive procedure for the analysis of benzodiazepines, with limits of quantitation of 5 ng/mL.

This study focuses on the automated extraction of small sample volumes coupled to LC/MS/MS in order to provide high throughput analysis for drugs of abuse such as benzodiazepines. Using a GERSTEL MPS 2 autosampler, the DPX extractions were performed using a mixed-mode cation exchange (DPX-CX) sorbent. The resulting eluents from the automated DPX extractions were then introduced into an Agilent 6410 LC/MS/MS instrument.

AppNote-2009-07
Analysis of Drugs of Abuse using Automated Disposable Pipette Extraction and LC/MS/MS